These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 12193859)

  • 1. [Changes in chemotherapy for pancreatic adenocarcinoma].
    Hammel P
    Gastroenterol Clin Biol; 2002; 26(6-7):603-4. PubMed ID: 12193859
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chemotherapy in adenocarcinomas of the pancreas].
    Huguier M
    Gastroenterol Clin Biol; 2002 Nov; 26(11):1063; discussion 1063-4. PubMed ID: 12483149
    [No Abstract]   [Full Text] [Related]  

  • 3. [5-FU, folinic acid and cisplatin (LV5FU2-P) for unresectable pancreatic cancer].
    Taïeb J; Lecomte T; Ezenfis J; Artru P; Mitry E; Boige V; Clavero-Fabri MC; Vaillant JN; Rougier P; Ducreux M
    Gastroenterol Clin Biol; 2002; 26(6-7):605-9. PubMed ID: 12193860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy.
    Kosakamoto H; Okada S; Ueno H; Okusaka T; Ikeda M; Tanaka N; Yoshimori M; Matsuno Y
    Hepatogastroenterology; 1999; 46(28):2621-4. PubMed ID: 10522052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of preoperative combined radiation therapy and chemotherapy with 5-fluorouracil and cisplatin in potentially resectable pancreatic adenocarcinoma: The French SFRO-FFCD 97-04 Phase II trial.
    Mornex F; Girard N; Scoazec JY; Bossard N; Ychou M; Smith D; Seitz JF; Valette PJ; Roy P; Rouanet P; Ducreux M; Partensky C
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1471-8. PubMed ID: 16793214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma.
    Raymond E; de Gramont A; Louvet C; Tournigand C; Demuynck B; Beerblock K; Carola E; Krulik M
    Eur J Cancer; 1997 Apr; 33(4):696-7. PubMed ID: 9274458
    [No Abstract]   [Full Text] [Related]  

  • 7. The case for routine use of adjuvant therapy in pancreatic cancer.
    Kennedy EP; Yeo CJ
    J Surg Oncol; 2007 Jun; 95(7):597-603. PubMed ID: 17230543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie.
    Al-Batran SE; Hartmann JT; Probst S; Schmalenberg H; Hollerbach S; Hofheinz R; Rethwisch V; Seipelt G; Homann N; Wilhelm G; Schuch G; Stoehlmacher J; Derigs HG; Hegewisch-Becker S; Grossmann J; Pauligk C; Atmaca A; Bokemeyer C; Knuth A; Jäger E;
    J Clin Oncol; 2008 Mar; 26(9):1435-42. PubMed ID: 18349393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxaliplatin, 5-fluorouracil, and leucovorin as second-line treatment for advanced pancreatic cancer.
    Novarino A; Satolli MA; Chiappino I; Giacobino A; Bellone G; Rahimi F; Milanesi E; Bertetto O; Ciuffreda L
    Am J Clin Oncol; 2009 Feb; 32(1):44-8. PubMed ID: 19194124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase II trial of infusional fluorouracil, leucovorin, mitomycin, and dipyridamole in locally advanced unresectable pancreatic adenocarcinoma: SWOG S9700.
    Isacoff WH; Bendetti JK; Barstis JJ; Jazieh AR; Macdonald JS; Philip PA
    J Clin Oncol; 2007 May; 25(13):1665-9. PubMed ID: 17470859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intra-arterial infusion chemotherapy with 5-fluorouracil and cisplatin in advanced pancreatic cancer: a feasibility study.
    Sasada T; Denno R; Tanaka T; Kanai M; Mizukami Y; Kohno S; Takabayashi A
    Am J Clin Oncol; 2008 Feb; 31(1):71-8. PubMed ID: 18376231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial infusion chemotherapy for the patient of unresectable pancreatic carcinoma with multiple liver metastases: a case report.
    Fujii M; Miyake H; Sasaki K; Takagi T; Takamura K; Tashiro S
    J Med Invest; 2003 Aug; 50(3-4):199-202. PubMed ID: 13678391
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of TP53 status for primary cisplatin, fluorouracil, and leucovorin chemotherapy in ethmoid sinus intestinal-type adenocarcinoma.
    Licitra L; Suardi S; Bossi P; Locati LD; Mariani L; Quattrone P; Lo Vullo S; Oggionni M; Olmi P; Cantù G; Pierotti MA; Pilotti S
    J Clin Oncol; 2004 Dec; 22(24):4901-6. PubMed ID: 15611505
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of the paclitaxel, cisplatin, 5-fluorouracil and leucovorin (TPFL) regimen in the treatment of advanced or metastatic gastric cancer.
    Jung JY; Kwon JH; Kim JH; Song HH; Kim I; Lee KS; Kim HJ; Zang DY; Ahn JS; Lee JA; Park YI
    Oncol Rep; 2009 Feb; 21(2):523-9. PubMed ID: 19148531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional celiac artery infusion in the adjuvant treatment of pancreatic cancer.
    Papachristou E; Link KH; Schoenberg MH
    Anticancer Res; 2003; 23(2A):831-4. PubMed ID: 12820308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ifosfamide plus 5-fluorouracil for treatment of adenocarcinoma of the pancreas.
    Loehrer PJ; Williams SD; Nichols CR
    Cancer Treat Rep; 1987 Nov; 71(11):1115-6. PubMed ID: 3119208
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant chemotherapy with cisplatin, etoposide, fluorouracil and leucovorin for gastric carcinoma.
    Papadakou M; Xydakis E; Bonios M; Makropoulou E; Boukis C; Kakavoulis T; Karaliotas C; Panagos G
    J BUON; 2006; 11(3):285-9. PubMed ID: 17309151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study.
    Louvet C; Beerblock K; de Gramont A; Varette C; Demuynck B; Bennamoun M; Cady J; Delfau S; Maisani JE; Krulik M
    Eur J Cancer; 1993; 29A(8):1217. PubMed ID: 8518038
    [No Abstract]   [Full Text] [Related]  

  • 19. [A case of curatively resected gastric cancer through an effective response to chemotherapy].
    Ema T; Arai K; Maeda Y; Iwasaki Y; Katayanagi S; Takahashi K; Yamaguchi T; Takahashi T
    Gan To Kagaku Ryoho; 2004 Jun; 31(6):925-8. PubMed ID: 15222114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase I/II trial of intraperitoneal 5-Fluorouracil with and without intravenous vasopressin in non-resectable pancreas cancer.
    Oman M; Lundqvist S; Gustavsson B; Hafström LO; Naredi P
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):603-9. PubMed ID: 16047145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.